SCHEMBL6312130

SCHEMBL6312130

CCOc1ccc(C(=O)COC(=O)c2ccccc2O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
L3MBTL1 Q9Y468 4/20 0.56
HTT P42858 2/20 0.56
KMT2A Q03164 2/20 0.56
NPC1 O15118 6/20 0.55
RAB9A P51151 3/20 0.55
KDM4E B2RXH2 2/20 0.55
USP2 O75604 1/20 0.55
CASP3 P42574 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
MAPT P10636 1/20 0.55
TSHR P16473 1/20 0.55
SIRT5 Q9NXA8 1/20 0.55
LMNA P02545 2/20 0.54
MEN1 O00255 1/20 0.54
TP53 P04637 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
KLF10 Q13118 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8208699 0.82 CYP1A2 (0.64) ALDH1A1L3MBTL1HTTKMT2ANPC1
SCHEMBL15079411 0.80 KMT2A (0.62) ALDH1A1L3MBTL1HTTKMT2ANPC1
SCHEMBL10781090 0.80 HPGD (0.67) ALDH1A1L3MBTL1HTTKMT2ANPC1
SCHEMBL4456935 0.78 TDP1 (0.55) ALDH1A1L3MBTL1HTTKMT2ANPC1
SCHEMBL15079924 0.78 LMNA (0.73) ALDH1A1L3MBTL1HTTKMT2ANPC1
SCHEMBL12243295 0.77 ALDH1A1 (0.68) ALDH1A1L3MBTL1KMT2ANPC1RAB9A
SCHEMBL11760446 0.76 ALDH1A1 (1.00) ALDH1A1L3MBTL1KMT2ANPC1RAB9A
Ethyl Salicylate SCHEMBL1870434 0.76 TSHR (0.77) ALDH1A1L3MBTL1HTTKMT2ANPC1
Ethyl Salicylate SCHEMBL39622 0.76 TSHR (0.77) ALDH1A1L3MBTL1HTTKMT2ANPC1
Ethyl Salicylate SCHEMBL29501114 0.76 TSHR (0.77) ALDH1A1L3MBTL1HTTKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140336178-A1 COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES THE GENERAL HOSPITAL CORPORATION (US) 2014-11-13 US disclosed
US-20140336178-A1 COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES THE GENERAL HOSPITAL CORPORATION (US) 2014-11-13 US disclosed
US-20140336178-A1 COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES THE GENERAL HOSPITAL CORPORATION (US) 2014-11-13 US disclosed
US-20130203733-A1 COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-08-08 US disclosed
US-20130203733-A1 COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-08-08 US disclosed
US-20130203733-A1 COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2013-08-08 US disclosed
US-8404747-B2 Compositions and methods for modulating interaction between polypeptides THE GENERAL HOSPITAL CORPORATION (US) 2013-03-26 US disclosed
US-8404747-B2 Compositions and methods for modulating interaction between polypeptides THE GENERAL HOSPITAL CORPORATION (US) 2013-03-26 US disclosed
US-8404747-B2 Compositions and methods for modulating interaction between polypeptides THE GENERAL HOSPITAL CORPORATION (US) 2013-03-26 US disclosed
US-20050239833-A1 Compositions and methods for modulating interaction between polypeptides MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239833-A1 Compositions and methods for modulating interaction between polypeptides IAPP, SERPINA6, SERPINA2 ALDH1A1 4852/4885L3MBTL1 479/4885HTT 227/4885
US-20130203733-A1 COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES IAPP, SERPINA6, SERPINA2 ALDH1A1 4852/4885L3MBTL1 479/4885HTT 227/4885
US-20140336178-A1 COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES IAPP, SERPINA6, SERPINA2 ALDH1A1 4852/4885L3MBTL1 479/4885HTT 227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.